Coral Laboratories Limited

₹500.15As of Sun 8 Nov 2026, 12:00 UTC
BSE:524506Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR (1.58%)
Div yield 0.40%
ROE 7.99%
Pharmaceutical Preparations
Beta (5Y) 0.85
PE TTM 9.306
TSR TTM (1.47%)
Mkt cap ₹1.787B
ROIC 8.01%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹647
29.39%
(69.69%)
Hold 0|10|1|5|12
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
4.86
4.82
4.87
5.16
14.23%
9.30%
10.73%
7.93%
Revenue₹M
116.4
113.7
116.8
116.5
1.04%
(0.79%)
3.66%
(1.47%)
Peers (US$18.95M)
Cap (US$)
PE
18.82M
5.918x
19.32M
8.765x
Capital
TTM
5Y
10Y
Leveragex
4.682
—
—
EBIT/Intx
0.079
0.258
0.256
Own earn%
(33.74)
(0.65)
(30.62)
Sh yield%
40.93
17.21
21.02
Owners
Insiders/Inst%
1.77
67.05
Short interest%
5.82
SBC / revenue%
1.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
20–30
$1 testx
—
Incr. ROIC%
68